Estimating the standardized incidence ratio (SIR) with incomplete follow-up data by Becher, Heiko & Winkler, Volker
RESEARCH ARTICLE Open Access
Estimating the standardized incidence ratio
(SIR) with incomplete follow-up data
Heiko Becher1* and Volker Winkler2
Abstract
Background: A standard parameter to compare the disease incidence of a cohort relative to the population is
the standardized incidence ratio (SIR). For statistical inference is commonly assumed that the denominator, the
expected number of cases, is fixed. If a disease registry is available, incident cases can sometimes be identified
by linkage with the registry, however, registries may not contain information on migration or death from other
causes. A complete follow-up with a population registry may not be possible. In that case, end-of-follow-up date
and therefore, exact person-years of observation are unknown.
Methods: We have developed a method to estimate the observation times and to derive the expected number
of cases using population data on mortality and migration rates. We investigate the impact of the underlying
assumptions with a sensitivity analysis.
Results: The method provides a useful estimate of the SIR. We illustrate the method with a numerical example, a
simulation study and with a study on standardized cancer incidence ratios in a cohort of migrants relative to the
German population. We show that the additional variance induced by the estimation method is small, so that
standard methods for inference can be applied.
Conclusions: Estimation of the observation time is possible for cohort studies with incomplete follow-up.
Keywords: Epidemiological methods, Cohort studies, Incidence, Missing data, Standardized incidence ratio
Background
The analysis of epidemiologic cohort studies usually re-
quires person-years (py) calculation to measure the exact
time at risk. Person-years are not only used to compute
different rates within a cohort resulting in e.g. rate ratios
(RR), but also to calculate the commonly applied stan-
dardized incidence or mortality ratio (SIR, SMR) to
compare the observed number of certain events with the
expected number given the rates in the underlying popu-
lation [1]. A SIR or a SMR estimates the occurrence of
an event in a population relative to what might be
expected if the population had the same experience as
some larger comparison population designated as
‘normal’ or average or reference.
To be able to calculate the exact accumulated number
of person-years within a cohort, the dates (i) begin of
follow-up and (ii) end of follow-up must be known for
each individual. For estimating the SIR, the date of
disease onset and reference incidence rates for compari-
son (to calculate the expected number of cases) must
also be available. The latter may come from disease
registries, e.g. a cancer registry. The end of the observa-
tion period is defined as the minimum of date of death,
date of disease onset and end-of-follow-up/lost-to-fol-
low-up date.
Statistical inference for the SIR and the SMR is usually
based on the assumption that the denominator is fixed
and that the numerator is Poisson distributed. Both ap-
proximate and exact solutions have been developed [1].
The analysis is implemented in common software pro-
grams like SAS, R or STATA. Few authors, however,
have considered the case when the denominator must be
considered as random. Silcocks showed that the beta
distribution can be used for statistical inference when
the expected number of events is subject to random
variation [2]. More recently, Beyene and Moineddin
compare methods for measuring the “location quotient”,
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which is the relative contribution of a rate in a subset
(size ni) to the whole population (size n) [3]. In both of
these cases the variance of the denominator cannot be
neglected because the underlying population is large
enough relative to the study population.
In the present case, a different situation is considered
which has not been paid much attention. While the link-
age of a cohort with a disease registry may be straight
forward, the linkage with the population registry may be
hampered by bureaucracy, data protection issues, costs,
or other reason. In that case the exact person-years are
unknown. This was the case for a cohort study con-
ducted by us and motivated the present work.
In this paper we present a method to estimate the SIR
and to perform statistical inference under the following
situation: (i) The cohort is fully defined and information
on basic covariates (date of birth, date of entry into co-
hort, sex, covariates where appropriate) is complete (ii)
incident cases of the disease(s) of interest have been
identified through linkage with a disease registry, with
date of disease onset known. This registry may cover the
geographical area from which the cohort originated, but
not necessarily the whole country (iii) a mortality
follow-up is not available, i.e. it is unknown if a person
died of a disease other than the disease of interest, and it
is unknown whether and when a person moved out of
the catchment area of the disease registry.
This situation is not uncommon. In the second sec-
tion, we provide the estimate, a procedure to implement
this in SAS, an estimate for the variance, and give
recommendations for a sensitivity analysis. In the third
section, we illustrate the procedure with a simple artifi-
cial example.
In the fourth section we investigate properties of the
estimation procedure with a simulation study. In the
fifth section, we present data from a cohort study in
which this situation occurred [4]. It is a study on immi-
grants from the Former Soviet Union in a German state
(Saarland) where we calculated the SIR for cancer, based
on linkage with the Saarland cancer registry. This study
was performed with 18 621 migrants from the Former
Soviet Union who immigrated between 1990 and 2005 to
the German federal state of Saarland. For every individual,
name, sex, date of birth, date of immigration (start of the
observation period), and first city of residence was avail-
able. A complete incidence follow-up was done by linking
the cohort with the Saarland cancer registry which is a
high quality register for this federal state [5]. 470 incident
cancer (except non-melanoma skin cancer) cases were
identified. Mortality follow-up and tracing of individuals
who relocated from the state, however, was not per-
formed. We present a sensitivity analysis to assess the
effect of the assumptions made in the method. Finally, we
discuss the relevance of our findings.
Methods
Outline and notations
We consider data of a cohort with N individuals num-
bered as n = 1, …, N where date of birth, date of begin-
ning of follow-up, sex and possibly other covariates are
known. We assume further that a disease registry exists
which covers the geographical area from which the co-
hort was selected. Linkage with this disease registry
yields the date of diagnosis for those diseased before a
fixed follow-up date. Then, for each individual the date
of diagnosis for those diagnosed within the catchment
area of the registry (in the following: study area) or no
information on the end of follow-up is given. Thus, four
events are possible for each individual as given in Fig. 1.
Event 1) person was identified as incident case
(person D)
Event 2) person died from a cause other than the
disease of interest at date di (person B)
Event 3) person moved out of the study area at date di
(person C)
Event 4) person is alive at the end of follow-up date
and residing in the study area (person A)
Events of person B and C are not observed. An as-
sumption that all these individuals contribute person-
years until the end-of-follow-up date is incorrect and
would overestimate the person-years and hence under-
estimate the SIR. The SIR for a disease D is estimated by
the ratio of observed O and expected cases E. E is calcu-
lated as
E ¼
X
i;j
pyi j λi j
where pyij are the observed person-years in the full co-
hort for age group i and calendar-period j, and λij the
Fig. 1 Illustration of possible events during a follow-up procedure
for individuals entering the cohort at variable dates
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corresponding incidence rates for disease D in the
reference population.
For the estimation according to the later proposed
method we need the mortality rates for all other
diseases except D, and the out-migration rates. Both
may be age- and period-dependent, and we denote
these as μij and νij , respectively.
To introduce the method for person-years estimation,
we also need the estimated person-year contribution of
an individual n for year 1, 2 … . We denote this as cpy
i1n
,cpy
i2n
etc. Year 1 denotes the first calendar year in which
cohort members contribute observation time.
Person-years estimation with incomplete follow-up for a
single individual
In order to estimate pyij from the available data, we
assume that mortality rates for causes other than the
disease of interest μij which can be applied to the cohort
(by age and calendar period) (event 2) and the migration
rates νij (event 3) are available. Note that the following
applies to the cohort members who did not become inci-
dent cases during the follow-up. For these incident
cases, person-times are exactly known and can be
assigned to age groups and calendar periods as usual.
For sake of simpler presentation we assume for a mo-
ment that follow-up start and birthday is January 1st. We
assume further for a moment that age groups and calen-
dar periods of one year are considered, that the expected
person-year contribution for an individual n for which
one of the events occurred in a year is 0.5 years, and that
the events 1,2,3 are independent. Then, the estimated
person-year contribution for individual n which is not
an incident case belonging to age i at calendar year 1
after entry into the study, cpy
i1n
, is
bpyi1n ¼ 1−μi1ð Þ 1−νi1ð Þ þ 0:5 μi1 þ νi1−μi1νi1ð Þ
¼ 1−γi1
 þ 0:5γ i1
With
γ i1 ¼ μi1 þ νi1−μi1νi1 ð1Þ
We can assume small rates, so γi1 can be approximated
by γi1 = μi1 + νi1. So if, for example, μi1 = 0.002 and νi1=
0.013, then γi1 = 0.002 + 0.013 − 0.002 × 0.013 = 0.015 −
0.000026 = 0.014974 ≈ 0.015, and an estimate for the
person-year contribution in the first year is (1–0.015) +
0.5 × 0.015 = 0.9925 person-years instead of a full person-
year. In other words, from 1000 individuals in that age
group who did not get the disease of interest, an expected
number of 15 individuals either die from another disease
or migrate within a year. Each of these 15 individuals
contribute an expected half person-year (since a uni-
form distribution of the time of occurrence of the
events within a year can be assumed), so the expected
total number of person-years for these 1000 individuals
is 985 + 15x0.5 = 992.5 person-years, i.e. 0.9925 per per-
son. For year 2 calculation is similar: From 1000 indi-
viduals in that age group who did not get the disease of
interest, an expected number of 15 either died from
another disease or migrated in the first year and there-
fore do not contribute person-time for the second year.
From the remaining 985 individuals, 985 × 0.015 =
14.775 are expected to die or migrate in the second
year, i.e. 985–14.775 = 970.225 contribute a full year of
observation time in the second year. So the expected
total number of person-years for the initial 1000 indi-
viduals for the second year is (970.225 + 14.775 × 0.5) =
977.612 person-years, i.e. 0.977612 per person. The
general equation for the second year is thus
bpyi2n ¼ 1−γi2 þ 0:5γ i2 P survive year 1ð Þ
¼ 1−0:5γ i2
 
1−γ i1
  ð2Þ
This procedure continues for an arbitrary year k until
the end-of-follow-up-date as
bpyikn ¼ 1−0:5γ ik Yk−1
κ¼1
1−γiκ
  ð3Þ
This can be rewritten as
bpyikn ¼ 1−0:5γ ik 1−γ i;k−1 Yk−2
κ¼1

1−γ iκ

¼

1−0:5γ ik

1−γ i;k−1
 
1−0:5γi;k−1
  bpyi;k−1;n
ð4Þ
Since
1−0:5γ ikð Þ 1−γ i;k−1ð Þ
1−0:5γ i;k−1ð Þ is numerically close to (1 − γi,k)
unless the rates change strongly from one year to the next,
we use the simpler equation
bpyikn ¼ 1−γij  bpyi;k−1;n ð5Þ
A full numerical example is given in Table 1. In a co-
hort individual entry dates and birth dates are arbitrary,,
and the calendar period changes over time and so do the
corresponding rates μij and νij.. We now use the
common notation for person-years which are given ac-
cording to age groups. In praxis, 5-year age groups i =
1, .., I are commonly used. We use this grouping in
the following. The expected person-time that an indi-
vidual n contributes to the age class i × calendar year j,
j = 1, …, J , cpy
ijn
is then given as the probability that
the class is entered multiplied by the expected obser-
vation time within that class. The probability that the
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class is entered is the product of the failure probabili-
ties in all previous age × calendar year classes (i’,j’), i.e.Y
i0; j0;
i0 < i; j0 < j
i0; j0ð Þ≠ i; jð Þ
1−γ i0j0py

i0j0n
 
, where γi ' j 'is the sum of the
mortality and migration rate in class (i,j) and pyi ' j ' n
* is
the maximal person-time (raw person-years) in that class
(which is 1 year under this categorization), and thus we
get
bpyijn ¼ Y
i0; j0;
i0 < i; j0 < j
i0; j0ð Þ≠ i; jð Þ
1−γ i0j0py

i0j0n
 
0BBBBBBBB@
1CCCCCCCCA
pyijn 1−0:5γ ij
 
ð6Þ
Equation (6) is the general form of Eq. (3) which al-
lows arbitrary entry times, birth dates, and class length.
Summing up the expected person-years for each cohort
member over all age-groups and calendar years then
gives an estimate for the expected person-years in all
categories, cpyij ¼XN
n¼1
bpyijn . The person-years from the
cases pyij,cases have to be added. An estimate for the SIR
is then given by
SIR ¼ OXI
i¼1
XJ
j¼1
cpyij þ pyij;cases  λij
ð7Þ
Computational aspects
In principle, the person-years contributions for each in-
dividual for each calendar year and age class can be cal-
culated separately, and thus the estimate in Eq. (6) can
be used directly. Computationally, it is simpler to first
calculate the person-years by age group and calendar
period under the assumption μij = νij = 0, i.e. for all indi-
viduals not diseased the study endpoint is used as end of
follow-up date for all individuals. Common software to
calculate person-years is applied here and gives the ‘raw’
person-years which we have denoted as pyij
* . This also is
the upper bound for the total person-years and can be
used to calculate the minimal SIR. We apply the above
Table 1 Numerical example: expected person-year contributions and calculation procedure for a single individual
Rates (per 1000) E(pyj) Sensitivity analysis
E(pyj)
Year (j) Age (i) μij νij λij Var(pyj) (fixed rates) Var(pyj) (variable rates) Factor for μij 0.5 and νij 1.5
1990 40 2 13 0.5 0.992 0.004 0.01725 0.9925 0.9775
1991 41 2 13 0.5 0.978 0.019 0.03384 0.9851 0.9558
1992 42 2 13 0.5 0.963 0.035 0.04979 0.9777 0.9449
1993 43 2 13 0.5 0.949 0.050 0.06513 0.9704 0.9238
1994 44 2 13 0.5 0.934 0.066 0.07988 0.9632 0.9031
1995 45 3 10 0.8 0.921 0.078 0.09252 0.9569 0.8840
1996 46 3 10 0.8 0.908 0.087 0.1047 0.9507 0.8670
1997 47 3 10 0.8 0.896 0.097 0.11655 0.9446 0.8500
1998 48 3 10 0.8 0.884 0.106 0.12798 0.9385 0.8335
1999 49 3 10 0.8 0.872 0.114 0.13903 0.9324 0.8173
2000 50 5 7 1.2 0.860 0.122 0.14909 0.9268 0.8008
2001 51 5 7 1.2 0.849 0.129 0.15884 0.9213 0.7854
2002 52 5 7 1.2 0.838 0.136 0.16830 0.9157 0.7700
2003 53 5 7 1.2 0.827 0.143 0.17748 0.9103 0.7552
2004 54 5 7 1.2 0.816 0.149 0.18638 0.9048 0.7404
Total total 13.487 1.335 1.677 14.190 12.830
Date of birth:January 1st, 1950; Begin of follow-up: January 1st, 1990;
End of follow-up:December 31st, 2004
μij - mortality rate (all causes other than disease of interest), age i, year j
νij - migration rate, age i, year j
λij - incidence rate (disease of interest), age i, year j
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procedure iteratively from the first up to the last year of
follow-up as
bpyi1 ¼ pyi1 1−γi1  ð8Þ
similar as in Eq. (5). Here i is the index for age group
and 1 the first calendar year to which individual(s) con-
tribute person-times.
If the population did not undergo aging, the adjusted
person-years py in the second calendar year would be
bpyi2 ¼ pyi2− pyi1− bpyi1   1−γi2  ð9Þ
since to the raw py in year 2 contribute individuals who
enter the cohort in year 2 and individuals who entered
in year 1. For the latter group, the expected loss of py in
the first year, pyi1− bpyi1 , must be taken into account and
subtracted from the raw py in year 2. On this adjusted
term, pyi2− py

i1− bpyi1  , the rates for the year 2 (1 − γi2)
must be applied. This procedure continues until the last
calendar year is reached for which observation times are
recorded.
In the iterative process we must take aging into ac-
count, i.e. people move through the underlying age
groups. Since mortality rates are commonly provided in
five year age groups we use this categorization as well.
For a given year, the observation times of a five-year age
group undergo aging such in expectation that one fifth
will move to the next oldest five-year age group in the
next year. The estimated person-years for the second
calendar year j2 of age group i, bpyi2 is therefore the raw
person-years, pyi2
* , minus 4/5 of the expected loss in the
same age group, minus 1/5 of the expected loss in the
next youngest age group, yielding
bpyi2 ¼ pyi2 − pyi1− bpyi 1  45 − pyi−1;1− bpyi−1;1  15
 	
1−γ i2
 
ð10Þ
Finally, for an arbitrary year j we get
bpyi;j ¼ pyi ;j − pyi ;j−1− bpyi; j−1  45 − pyi−1; j−1− bpyi−1; j−1  15 	 1−γ ij 
ð11Þ
We have written an SAS Macro to perform the re-
quired calculations (available as Additional file 1). As
mentioned before, the exact solution requires the pro-
cedure for the non-diseased only and adding the
(known) person-years from the diseased (the cases).
Variance estimation and confidence intervals
Standard procedures for SIR confidence intervals con-
sider the observed number of cases O as random vari-
able which is Poisson distributed and the denominator
as fixed. Our procedure to estimate the accumulated
person-years adds a variance component to the expected
number of deaths E, and therefore an additional variance
component must be taken into account. In the following
we show that this component is so small compared to the
component in the numerator that it can be neglected.
The delta-method asymptotically gives Var OE
  ¼ 1
E2
Var Oþ O2
E4
Var E . Since O is Poisson distributed, its
variance is equal to the expectation, i.e. Var(O) = E(O).
For Var (E) it holds:
Var Eð Þ ¼ Var
XI
i¼1
XJ
j¼1
^pyij λij
 !
¼
XI
i¼1
XJ
j¼1
λij
 2
Var ^pyijÞ
  
ð12Þ
The evaluation of Var cpyijÞ is done under the same
assumptions on entry times and ages as before. For the
first year (1) and for a single individual n, the variance of
its person-year contribution is Var py^i1nð Þ ¼
1
3−γ i1
4
 
γ i1 .
This is shown as follows: Let Y denote the random vari-
able denoting the (unknown) person-time for an indi-
vidual in the first year of observation. Its density
function is f Y yð Þ ¼
1−γ i1
γ i1


if
Y ¼ 1
Y∈ 0; 1ð Þ , assuming a
uniform distribution given an event (migration or death
from other cause) occurred. Then we get expectation
E(Y) = 1 × (1 − γi1) + 0.5 × γi1 = 1 − 0.5γi1. We are inter-
ested in the variance of Y. We use the relation Var(Y) =
E(Y2) − [E(Y)]2. For fZ(y), Z := Y
2 we get f Z zð Þ
¼ 1−γ i1
1= 2
ﬃﬃ
z
pð Þ


if
Z ¼ 1
Z∈ 0; 1ð Þ and then after basic
probability theory E(Z) = (1− γi1) + γi1/3 and thus Var(Y)
= (1− γi1) + γi1/3− (1− γi1/2)
2 = γi1/3− γi1
2 /4 = γi1(1/3− γi1/4).
For small rates, this is smaller than the binomial vari-
ance γi1(1 − γi1)by a factor of about 3. This follows intui-
tively since individuals with an event contribute between
zero and one person-years in the year of the event,
not zero. Then, for all individuals in this year and age
group i, we have Var py^i1ð Þ ¼ py^i1ð Þ
1
3−γi1
4
 
γ i1 . For the
second year, we have for a single individual Var
py^i2nð Þ ¼ 1−γ i2
 
γ i2þ
1
3−γ i2
4
 
γi2 . In order to show that
the variance component from the estimated person-
years is negligible it is sufficient to consider an
upper bound of the total variance of the expected
number of cases, E. and for all individuals in the
second year and age group i, we have as an upper
bound Var py^i2ð Þ ¼ py^i2ð Þ 1þ 0:52
 
1−γ i2
 
γ i2
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Summing up, we have as an upper bound
Var Eð Þ ¼
 XI
i¼1
XJ
j¼1
λij
 2
VarðcpyijÞ
!
¼
XI
i¼1
XJ
j¼1
λij
 2cpyij j−1þ 0:52  1−γ ij γ ij
 !
since λijpyij^ ¼ Eij ,the expected number of cases in age
group × calendar period (i, j), we write
Var Eð Þ ¼
XI
i¼1
XJ
j¼1
Eijλijcpyij j−1þ 0:52  1−γ ij γ ij
 !
ð13Þ
Therefore under the rare disease assumption
λij and γijsmall, the variance of the denominator is sev-
eral magnitudes smaller than the variance of the numer-
ator. Additional aspects on variance estimation can be
found in Additional file 2. The appropriateness of this
method has additionally been checked by simulation
using the numerical example below. The evaluation
shows that the value resulting from Eq. (13) is very low,
and that the variance is very small compared to the vari-
ance of the numerator. Therefore, it can be neglected
and standard methods to calculate the confidence inter-
val can be used.
Sensitivity analysis
The method developed provides an estimate for the
person-years and hence for the SIR if the mortality rates
and the migration rates are applicable to the cohort.
Since the question may arise whether the mortality rates
from the underlying population are applicable to the co-
hort and whether the migration rates are reliably esti-
mated, the question of bias may be more relevant than
the additional variance induced by the person-years
estimation. If γij is underestimated, the person-years are
overestimated, up to the maximum when γij is zero.
Conversely, if γij is overestimated, the person-years are
underestimated. We recommend to perform a detailed
sensitivity analysis by estimating the SIR with reasonably
modified migration and mortality rates (see example
below). As will be seen in the study example (section 4),
the SIR estimate is relatively robust against violations of
the assumptions. If migration rates are reliably esti-
mated, however subject to random variation, an addi-
tional variance component can easily be incorporated
(see numerical example below).
Results
A numerical example
A numerical example is given in Table 1 to show the effect
of the estimation procedure on the person-years allocation
in the (calendar year) × (age) cross-classification. We con-
sider one single individual n which entered the cohort on
January 1st, 1990. This person did not become an incident
case during the follow-up period. Therefore, death from
another cause or out-migration out of the catchment area
of the registry could have occurred at any date during
the follow-up period with death rates μij and migration
rates νij, depending on calendar year and age. We
assume different migration and mortality rates in
different age groups. According to this example, this
person with an unknown follow-up status contributes
an expected value of pyn1 =0.992 person-years to the
first year of follow-up, pyn2 =0.978 person-years to the
second, and pyn15 =0.816 person-years to the last year
of follow-up instead of a maximal value of one person-
years per year. The expected total number of person-
years for this person is 13.487 instead of a maximal
possible value of 15 years. These are realistic rates and
yield a reduction of person-years of 10.1%. If γij are as-
sumed fixed, the Variance of py(n)(1) is approximately
0.52γij(1 − γij)= 0.004, the variance of pyn2 and pyn3 is ap-
proximately (1 + 0.52)γij=0.019, and (2 + 0.5
2)γij=0.035,
and so on. The variance of the total person-years estimate
for this individual is 1.335. If γij are random with
variance var(γij) = σγ
2, we get var(pyn1)= γij(1 − γij) + σγ
2.
The variance component from the rates is here as-
sumed as σγ
2 = 0.052. Then the variance of the total
person-years estimate for this individual is 1.667, an
increase of 22%, however, still so small that it can be
neglected.
It would be incorrect to assign to this individual
13.429 person-years from the begin of follow-up since
this would wrongly yield to a fixed loss-to-follow-up
date in the year 2003, and hence full years of observation
for all previous years, and zero person-years for the year
2004.
In Additional file 3 we expand this numerical example
by assuming that we have a cohort of 1000 individuals
with the same characteristics as the individual above. It
shows numerically that the variance component induced
by the person-years estimate in the denominator of the
SIR is small compared to the variance component in the
numerator so that it can be neglected. The sensitivity
analysis for this dataset used rates with factors 1.5 and
0.75 yielded a bias in the SIR of only 7%. It shows that
the procedure is relatively robust against violations in
the rate estimates.
Simulation study
A simulation study has been performed to investigate
the performance of the estimation procedure. The setup
of the simulation is as follows: A cohort of size N = 1000
was simulated with parameters as in the preceding nu-
merical example. For each dataset, the number of
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observable events (incident cases) and unobservable
losses (deaths from other causes or out-migration)
and the corresponding failure time of the events and
time of loss was simulated. The exact number of
person-years was recorded and compared with the es-
timated number of person-years according to the
above procedure. The main parameter for comparison
was the relative difference of observed and exact
person-years, i.e. Δpy rel ¼ pyexact−pyestimatedpyexact .
According to the chosen parameters we observed
between 3 and 23 events (median 11, mean 10.75) and
between 145 and 218 losses from deaths or out-
migration within the 15 year observation period (median
179, mean 179.7). The simulation results regarding the
observed and estimated py as well as the absolute and
relative difference and number of events are given in
Table 2. We observe a slight underestimation of the true
person-years of 0.4% with an empirical 90% confidence
interval as (−1.0% – 1.9%). We conclude that the pro-
cedure is sufficiently accurate. In comparison we would
find a mean overestimation of the person-years of 10.7%
if all individuals are wrongly assumed to remain under
risk.
The simulation program was written in SAS and is
listed in the supplemental material.
Application
A cohort study was performed with 18621 migrants
from the Former Soviet Union who immigrated between
1990 and 2005 to the German federal state of Saarland.
For every individual name, sex, date of birth, date of im-
migration (start of the observation period), and first city
of residence was available. A complete incidence follow-
up was done by linking the cohort with the Saarland
cancer registry which is a high quality register for this
federal state [5]. 470 incident cancer cases (except non-
melanoma skin cancer) were identified. Mortality follow-
up and tracing of individuals who relocated from the
state was not performed.
Age, sex and calendar-year specific “raw” person-
years were calculated at the end of the observation
period (31st December 2005) by calendar year and 5-
year age groups. For individuals with cancer diagno-
sis, the date of diagnoses was set as the endpoint of
their observation time. A summarized result is given
in Table 3.
Adjustment of the person-years was done accord-
ing to Eqs. (1) and (2). The German mortality rates
for all causes of death except cancer within the
cohort (μij) were used. These were obtained from
WHO mortality database [6]. The migration rates
(νij) were taken from a partial follow-up and from a
similar study on migrants in another federal state [7].
This is considered the most appropriate model. The
rates are given in Table 4 (model 1). The cancer inci-
dence rates λij were taken from the Saarland cancer
registry.
Table 5 gives the “raw” and adjusted person-years for
the 5-year age groups and calendar periods for the co-
hort. The overall cancer SIR is 1.11 in males and 1.01 in
females. Using the “raw” person-years for calculating E,
the SIR would be 0.90 and 0.86. The difference between
“raw” and estimated total person-years was 18959.7
person-years, or 11.3%.
The sensitivity analysis is done by estimating the num-
ber of person-years with different assumptions on migra-
tion rates. Model 2 uses halved and model 3 doubled
rates (see Table 4). Results of the estimation procedure
in terms of person-years and expected number of cancer
cases are shown in Table 5 for selected cancer sites
based on Saarland incidence rates [8]. Relatively little
Table 2 Simulation studya. Comparison of exact and estimated person-years
Parameter Mean Standard deviation Median Interquartile range
Person-years (exact) 13466.0 114.7 13467.1 13390.0 – 13544.2
Person-years (estimated) 13409.2 44.3 13408.5 13381.4 – 13435.6
Person-years (biased, if deaths/migration ignored) 14905.3 31.9 14907.2 14884.9 – 14926.9
Number of events 10.95 3.26 11 9 – 13
Number of deaths or migrants 179.7 179 179 172 - 188
Difference exact – estimated person - years 56.8 116.9 58.5 −21.15 – 134.2
Relative difference exact – estimated (in %) 0.41 0.86 0.43 −0.16 – 0.99
aParameter for the simulation
Number of simulation runs 1000
Number of observations 1000
Follow-up duration 15 years
Incidence rates (variable, see table 1)
Mortality rates (variable, see table 1)
Migration rates (variable, see table 1)
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variation between the different models is observed. The
biggest difference to model 1 for the expected number
of cases is seen for model 2 in all female cancers with
22.3 cases. For other cancer sites the maximum differ-
ences (found between models 1 and 2) in incident can-
cer cases are 4.3 and 6.8, respectively. Sensitivity analysis
demonstrates that estimated expected number of cancer
cases and therefore corresponding SIR are quite robust
with regard to the underlying assumptions. SIR for dif-
ferent cancer sites according to different models are also
shown in Table 5 with the respective standard 95% con-
fidence intervals. Model 4 gives the lower limit of the
SIR estimates using the raw person-years for calculating
the expected number of cases. On average, the expected
number of cases are about 25% higher in this model.
Discussion
We have presented a method to estimate the standardized
incidence ratio in a cohort study for which a linkage with
a disease registry has been performed, however, for which
a mortality follow-up including tracing of individuals
which moved out was not directly possible. This situation
is not a rare one: cancer registries exist in many parts of
the world, and disease registries for other diseases, such as
Table 3 Raw and adjusted person-years, Cohort study in Saarland, Germany, 1990-2005
Raw person-years Adjusted person-years
Calendar period Calendar period
Age 1990–1994 1995–1999 2000–2005 Total 1990–1994 1995–1999 2000–2005 Total
0 – 4 2435.1 5111.7 3459.0 11005.8 2247.5 4753.9 3115.3 10116.6
5 – 9 1618.1 5844.4 7102.9 14565.4 1467.5 5363.9 6564.7 13396.1
10 – 14 1670.8 5352.9 9988.2 17011.8 1516.5 4873.0 9285.1 15674.6
15 – 19 1521.3 4928.9 9379.4 15829.7 1372.4 4470.7 8628.2 14471.3
20 – 24 1876.9 4221.0 8320.0 14417.9 1686.7 3760.0 7580.1 13026.7
25 – 29 2724.3 5295.8 6974.0 14994.1 2464.6 4704.2 6207.7 13376.4
30 – 34 2802.5 7195.7 8072.7 18071.0 2583.7 6608.9 7221.2 16413.8
35 – 39 1864.9 6733.4 10915.2 19513.5 1718.6 6238.8 10011.3 17968.8
40 – 44 635.5 4408.0 10522.7 15566.2 573.2 4085.4 9707.7 14366.2
45 – 49 973.1 1631.1 7272.1 9876.2 890.3 1429.1 6667.3 8986.7
50 – 54 1145.8 2608.9 2883.5 6638.2 1071.9 2328.1 2408.7 5808.7
55 – 59 1035.9 2806.0 3706.3 7548.3 969.7 2501.0 2863.3 6647.3
60 – 64 926.1 2608.6 4174.2 7708.8 865.2 2291.1 3575.4 6731.7
65 – 69 422.2 1907.7 3541.6 5871.6 386.9 1655.4 2922.3 4964.5
70 – 74 281 855.5 2713.2 3849.6 252.2 690.2 2169.6 3112.0
75 – 79 200.5 572.8 1154.5 1927.9 175.3 432.3 758.8 1366.4
80 – 84 93.4 394.8 761.9 1250.2 76.0 273.2 421.1 770.4
85+ 19.3 199.5 845.8 1064.6 13.2 109.4 430.2 552.8
Total 22246.7 62676.7 101787.2 186710.8 20331.3 56568.5 90851.3 167751.1
Table 4 Yearly migration rates for three different models, Cohort study in Saarland, Germany, 1990–2005
Migration rates νij
Before 1993 1993 to 1996 After 1996
Age
<30
Age
30–50
Age
>50
Age
<30
Age
30–50
Age
>50
Age
<30
Age
30–50
Age
>50
Model 1
(external estimate)
6.5% 5.5% 2.5% 2.2% 1.1% 2.5% 0.4% 0.4% 0.8%
Model 2
(two times lower than model 1)
3.25% 2.75% 1.25% 1.1% 0.55% 1.25% 0.2% 0.2% 0.4%
Model 3
(two times higher than model 1)
13.0% 11.0% 5.0% 4.4% 2.2% 5.0% 0.8% 0.8% 1.6%
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diabetes, stroke, and others have been developed, e.g. [9,
10]. A straightforward mortality follow-up is possible only
in countries with a death register or comparable data re-
sources, such as for example the US, Great Britain and the
Scandinavian countries. For many other countries, such as
Germany, Switzerland, France, Italy, Spain and others the
method presented here is an alternative to the sometimes
heavily bureaucratic mortality follow-up procedures.
Epidemiologists use these registries to assess disease inci-
dence, and a linkage of cohorts with these registries is
technically straightforward. We showed that under quite
robust assumptions it is possible to estimate the accumu-
lated number of person-years, and provided a method to
calculate the SIR and its 95% confidence intervals taking
into account the estimation procedure.
In our example, we present the analysis of cancer inci-
dence in a cohort by making assumptions on mortality
from other causes and on migration. First, the same
mortality as the German population within the cohort
was taken. Results from a similar cohort show that this
assumption may be reasonable [4]. A slight underesti-
mate of the number of person-years is possible, though.
The second assumption refers to migration. There are
good estimates on migration by age group from other
cohort studies in Germany, and also on migrants from
the former Soviet Union who migrated to another state
in Germany. We think these rates can be applied here,
however, some uncertainty will remain. A small subset
of the cohort (about 20%) has been followed-up by now,
and results support our assumption.
Here, we have considered cancer as the disease of
interest which can be regarded as a rare disease in terms
of the yearly incidence rates. If the disease is common,
then the time from begin of observation until disease
onset is shorter, and then for more individuals the raw
person-time is the correct person-time. Consequently,
the bias when using the raw person-years becomes
smaller.
Our sensitivity analyses were reassuring in that re-
spect. SIR estimates showed relatively little variation
with modified rate assumptions. Still, a bias in the esti-
mated expected value of cases is possible, and this ap-
pears to play a bigger role than the increase of variance
by the estimation procedure. We showed that the addi-
tional variance induced by variation in the denominator
is small relative to the variation in the number of
Table 5 Estimated person-years and expected cancer cases, and SIR according to different models, Cohort study in Saarland,
Germany, 1990–2005
Male Female
Observed Expected SIR
95% confidence interval
Observed Expected SIR
95% confidence interval
Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4
Person-years 81,193.4 74,377.9 84,907.6 90,510.7 86,557.7 79,308.5 90,505.8 96,200.2
All Cancersa 235 211.0
1.11
0.98, 1.27
189.0
1.24
1.09, 1.41
226.2
1.04
0.91, 1.18
261.1
0.90
0.79, 1.02
235 232.0
1.01
0.89, 1.15
209.7
1.12
0.99, 1.27
244.2
0.96
0.85, 1.09
274.5
0.86
0.75, 0.97
Stomach 27 8.3
3.25
2.14, 4.75
7.5
3.60
2.37, 5.26
8.8
3.07
2.02, 4.48
10.5
2.57
1.68, 3.75
21 6.8
3.09
1.91, 4.73
6.1
3.44
2.13, 5.27
7.1
2.96
1.83, 4.53
8.4
2.50
1.55, 3.83
Colorectal 18 31.0
0.58
0.34, 0.92
27.6
0.65
0.39, 1,03
32.8
0.55
0.33, 0.87
39.1
0.46
0.27, 0.73
39 31.9
1.22
0.87, 1.67
28.6
1.36
0.97, 1.86
33.6
1.16
0.83, 1.59
39.2
0.99
0.71, 1.36
Lung 61 36.2
1.69
1.31, 2.17
32.4
1.88
1.46, 2.42
38.3
1.59
1.24, 2.05
45.0
1.36
1.05, 1.74
6 15.7
0.38
0.14, 0.83
14.1
0.43
0.16, 0.93
16.6
0.36
013, 0,79
18.5
0.32
0.12, 0.71
Breast 57 72.1
0.79
0.61, 1.02
65.3
0.87
0.67, 1.13
75.8
0.75
0.58, 0.97
83.6
0.68
0.53, 0.88
Prostate 35 37.6
0.93
0.65, 1.29
33.3
1.05
0.73, 1.46
40.0
0.88
0.61, 1.22
48.7
0.72
0.50, 1.00
Leukaemia 9 5.9
1.53
0.70, 2.90
5.4
1.67
0.76, 3.17
6.3
1.43
0.65, 2.71
7.1
1.27
0.58, 2.41
7 5.2
1.35
0.54, 2.77
4.7
1.49
0.60, 3.07
5.5
1.27
0.51, 2.62
6.2
1.13
0.45, 2.33
aexcept nonmelanoma skin cancer
Model 1– migration based on available data
Model 2 – assuming doubled migration of model 1
Model 3 – assuming halved migration of model 1
Model 4 – raw person-years
Becher and Winkler BMC Medical Research Methodology  (2017) 17:55 Page 9 of 10
observed cases. This allows using standard method of in-
ference, in particular the application of exact confidence
intervals if the observed number of cases is small.
The completeness of the registry is another relevant
issue. In the case of the cancer registry in the Saarland,
the percentage of DCO (death certificate only) cases in
the registry is very low, and all those cases within the co-
hort are likely to have been identified with the linkage
procedure.
Conclusions
We showed that valid estimation of the observation time
is possible for cohort studies with incomplete follow-up
data. This is especially relevant for cohort studies where
a complete assessment of the individual vital status is
not easily possible but which can be linked to disease
registries in order to assess the number of incident cases
within the cohort.
Additional files
Additional file 1: py estimation macro for SAS. (DOCX 17 kb)
Additional file 2: Addition aspects on variance estimation. (DOCX 21 kb)
Additional file 3: Numerical example showing py and variance
estimation. (DOCX 37 kb)
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